SCHEMBL16022232

SCHEMBL16022232

Cc1cc(C)c(N)c(C(C)(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
POLB P06746 2/20 0.52
CA2 P00918 1/20 0.52
TYR P14679 1/20 0.52
KDM4E B2RXH2 5/20 0.43
HSPA5 P11021 1/20 0.42
TSHR P16473 3/20 0.42
TP53 P04637 2/20 0.42
CYP3A4 P08684 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
HIF1A Q16665 3/20 0.41
HSD17B10 Q99714 2/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1930777 0.90 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2POLBCA2TYR
Water SCHEMBL28586819 0.87 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL22050670 0.85 POLB (0.46) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL29611318 0.85 POLB (0.46) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL8943131 0.85 POLB (0.65) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL8382333 0.83 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL10342450 0.83 POLB (0.70) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL5158750 0.83 POLB (0.50) ALDH1A1SMN1; SMN2POLBCA2TYR
Hydrochloric Acid SCHEMBL5424687 0.81 POLB (0.54) ALDH1A1SMN1; SMN2POLBCA2TYR
SCHEMBL22124842 0.81 KDM4E (0.45) ALDH1A1SMN1; SMN2POLBCA2TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230051589-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2023-02-16 US disclosed
US-10654816-B2 Compounds and compositions for treating conditions associated with NLRP activity NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-19 US disclosed
US-20200087270-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2020-03-19 US disclosed
US-10042258-B2 Composition for forming a resist upper-layer film and method for producing a semiconductor device using the composition NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-08-07 US disclosed
US-10042258-B2 Composition for forming a resist upper-layer film and method for producing a semiconductor device using the composition NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-08-07 US disclosed
US-9977331-B2 Resist overlayer film forming composition and method for producing semiconductor device including the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-05-22 US disclosed
US-9977331-B2 Resist overlayer film forming composition and method for producing semiconductor device including the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-05-22 US disclosed
US-9746768-B2 Resist overlayer film forming composition for lithography and method for producing semiconductor device using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-08-29 US disclosed
US-9746768-B2 Resist overlayer film forming composition for lithography and method for producing semiconductor device using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-08-29 US disclosed
US-20170205711-A1 COMPOSITION FOR FORMING A RESIST UPPER-LAYER FILM AND METHOD FOR PRODUCING A SEMICONDUCTOR DEVICE USING THE COMPOSITION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-07-20 US disclosed
US-9494864-B2 Resist overlayer film forming composition for lithography and method for manufacturing semiconductor device using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-11-15 US disclosed
US-9494864-B2 Resist overlayer film forming composition for lithography and method for manufacturing semiconductor device using the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-11-15 US disclosed
US-20150362835-A1 RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE USING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-12-17 US disclosed
US-20150362835-A1 RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE USING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-12-17 US disclosed
US-20150248057-A1 RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-09-03 US disclosed
US-20150248057-A1 RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING THE SAME NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-09-03 US disclosed
US-9046768-B2 Resist overlayer film forming composition for lithography NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-06-02 US disclosed
US-9046768-B2 Resist overlayer film forming composition for lithography NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-06-02 US disclosed
US-20140255847-A1 RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-09-11 US disclosed
US-20140255847-A1 RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200087270-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NLRP1, NLRP3, NOD1 ALDH1A1 1972/4885SMN1; SMN2 2608/4885POLB 4644/4885
US-20230051589-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NLRP1, NLRP3, NOD1 ALDH1A1 1999/4885SMN1; SMN2 2744/4885POLB 4639/4885
US-10654816-B2 Compounds and compositions for treating conditions associated with NLRP activity NLRP1, NLRP3, NOD1 ALDH1A1 1972/4885SMN1; SMN2 2608/4885POLB 4644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.